基因敲除
癌症研究
恶性肿瘤
基因沉默
重编程
巨噬细胞极化
肿瘤微环境
细胞培养
细胞
分泌物
生物
小干扰RNA
下调和上调
肿瘤进展
信号转导
化学
RNA干扰
转录组
细胞生长
小发夹RNA
癌变
上皮-间质转换
医学
作者
Xing Liu,Yalun Li,Lanlan Gao,Rihui Lu,Yongjin Fang,Xiao Song Yang
标识
DOI:10.1158/1541-7786.mcr-25-1164
摘要
Oral squamous cell carcinoma (OSCC) is a lethal malignancy characterized by frequent metastasis. Utilizing a 4-nitroquinoline 1-oxide-induced murine model and single-cell RNA sequencing, we identified a distinct collagen type I alpha 1 chain (Col1a1+) epithelial subpopulation that is significantly expanded in OSCC, exhibits the highest epithelial-mesenchymal transition (EMT) signature, and correlates with poor patient survival. Functional studies demonstrated that Col1a1 knockdown (KD) in OSCC cell lines (HSC3, SCC25) attenuated transforming growth factor β (TGF-β)-induced EMT, impaired migration and invasion in vitro, and reduced tumor burden in a conditional knockout mouse model. Transcriptomic profiling following Col1a1 silencing revealed the suppression of TGF-β signaling and extracellular matrix (ECM)-receptor interaction pathways. We further identified BMP1 as a key downstream effector, demonstrating a direct physical interaction between COL1A1 and BMP1, and showed that COL1A1 potentiates BMP1's proteolytic activity. Rescue experiments confirmed that BMP1 is essential for COL1A1-driven tumor growth, metastasis, and TGF-β pathway activation in vivo. Furthermore, we uncovered an immunomodulatory role for the COL1A1-BMP1 axis, whereby it promotes M2 macrophage polarization via TGF-β secretion to foster an immunosuppressive tumor microenvironment. This effect was reversible using either BMP1-KD or TGF-β neutralization. In conclusion, our study establishes a novel COL1A1-BMP1-TGF-β signaling cascade that drives OSCC progression by autonomously enhancing tumor cell malignancy and nonautonomously reprogramming the immune landscape, nominating this axis as a promising therapeutic target. IMPLICATIONS: These findings identify a novel COL1A1-BMP1 axis driving both OSCC malignancy and immunosuppression, offering potential diagnostic markers and therapeutic targets for the clinic.
科研通智能强力驱动
Strongly Powered by AbleSci AI